logo
ProjectEnded

BIONIC FEEDBACK SYSTEM FOR AMPUTEES AND DIABETICS

One of 3,761 projects Taiyo tracks in Austria.

Source: EU Funding & Tenders Portal

The BIONIC FEEDBACK SYSTEM. The Austrian company SAPHENUS Medical Technology, founded in 2016, has set itself the goal of improving the quality of people who lack the feeling in the legs, whether through polyneuropathy or through amputation. 1,5 million amputees and 7,5 million people with polyneuropathy and serious sensory problems are affected all over Europe. For these two target groups SAPHENU

Status
Closed
Sector
Hospital, Advanced Electronics
Location
Austria
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about BIONIC FEEDBACK SYSTEM FOR AMPUTEES AND DIABETICS

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “BIONIC FEEDBACK SYSTEM FOR AMPUTEES AND DIABETICS” is an infrastructure initiative in the Hospital sector, located in Austria. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The BIONIC FEEDBACK SYSTEM. The Austrian company SAPHENUS Medical Technology, founded in 2016, has set itself the goal of improving the quality of people who lack the feeling in the legs, whether through polyneuropathy or through amputation. 1,5 million amputees and 7,5 million people with polyneuropathy and serious sensory problems are affected all over Europe. For these two target groups SAPHENUS has the breakthrough solution using the bionic principle. With the Bionic Feedback System (BFS) the affected persons get back the feeling of the lost or damaged foot, they feel authentic again, and the brain is provided with sensory information again. SURALIS and CUTANEUS, the two BFS-products of SAPHENUS are patented high-tec add-on devices that consist of (i) a sensor sole and (ii) a transmission part which is applied on the stump or leg. SURALIS and CUTANEUS represent a new medical product category supporting cost-efficient, affordable, optimised care for amputees and diabetics. SAPHENUS has a strong network in medical research as well as in health insurances and in distribution partners. The SME-Instrument phase 1 business plan shall now be further implemented. The phase 2 workplan foresees a duration of 24 months and requests 1,8 mio of EC funding.

Location

Country

Austria

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Hospital, Advanced Electronics

Article published date

2026-02-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project